Trials / Active Not Recruiting
Active Not RecruitingNCT02978118
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 67 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This pilot study purpose of this study is to describe peripheral circulating immune cell profiles at baseline and change on treatment with immune checkpoint inhibitors in renal cell carcinoma and urothelial carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Immune cell and CTC detection procedures | Immune cell profiling assays (in blood and archival tumor samples) and circulating tumor cell assays (in blood samples) |
Timeline
- Start date
- 2017-03-07
- Primary completion
- 2028-10-01
- Completion
- 2028-10-01
- First posted
- 2016-11-30
- Last updated
- 2025-09-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02978118. Inclusion in this directory is not an endorsement.